The ‘elegant science’ in achieving the promise of ADCs episode artwork

EPISODE · Nov 7, 2023 · 15 MIN

The ‘elegant science’ in achieving the promise of ADCs

from pharmaphorum Podcast · host pharmaphorum

In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.

Episode metadata supplied by the publisher feed · Published Nov 7, 2023

Embed this episode

NOW PLAYING

The ‘elegant science’ in achieving the promise of ADCs

0:00 15:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 15 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on November 7, 2023.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!